Education Effect on Comfort and Anxiety in 5-FU Elastomeric Pump Therapy
EDUCAP-5FU
The Effect of Education on Comfort and Anxiety Levels in Patients Receiving 5-FU Treatment Administered With an Elastomeric Pump: A Randomized Controlled Trial
1 other identifier
interventional
70
1 country
2
Brief Summary
Cancer treatment often requires chemotherapy, which can be administered through portable devices called elastomeric pumps. These pumps allow medications such as 5-fluorouracil (5-FU) to be delivered continuously over an extended period while patients remain at home rather than staying in the hospital. Although this treatment approach offers greater convenience and independence, patients may experience anxiety and uncertainty related to pump use, treatment side effects, and self-care responsibilities. This study aims to determine whether providing structured education about elastomeric pump use and 5-FU treatment can improve patients' comfort and reduce anxiety. Participants receiving 5-FU chemotherapy through an elastomeric pump will be assigned to either an education group or a standard care group. Patients in the education group will receive additional training from the researcher using educational materials and a patient information booklet. The training will include information about safe pump use, management of treatment-related symptoms, precautions to take during treatment, and what to do if problems occur. Patients in the standard care group will continue to receive the routine information and care normally provided by the oncology clinic. Participants will complete questionnaires that measure comfort and anxiety before the study begins and again one month later. The results will help determine whether structured patient education improves the experience of individuals receiving outpatient chemotherapy through elastomeric pumps. The findings may help healthcare professionals develop more effective educational programs and supportive care strategies for patients receiving home-based chemotherapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable anxiety
Started Jul 2025
Shorter than P25 for not_applicable anxiety
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 2, 2025
CompletedStudy Start
First participant enrolled
July 8, 2025
CompletedFirst Posted
Study publicly available on registry
July 11, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 11, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 8, 2025
CompletedJune 15, 2026
November 1, 2025
1 month
July 2, 2025
June 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Anxiety (Beck Anxiety Inventory Score)
Change in anxiety level from baseline to one month post-intervention, measured using the Beck Anxiety Inventory. The Beck Anxiety Inventory is a 21-item self-report scale with scores ranging from 0 to 63. Higher scores indicate greater anxiety severity and therefore a worse outcome. Scores of 0-7 indicate minimal anxiety, 8-15 mild anxiety, 16-25 moderate anxiety, and 26-63 severe anxiety.
1 month
Secondary Outcomes (1)
Comfort (General Comfort Questionnaire-Short Form Score)
1 month
Study Arms (2)
5-FU Elastomeric Pump Education Program
EXPERIMENTALPatients will receive face-to-face training on the use of the elastomeric pump with 5-FU, supported by an educational booklet.
Standard Oncology Education and Care
NO INTERVENTIONPatients will receive standard institutional care without any additional education or training.
Interventions
This intervention involves a 15-20 minute face-to-face training session about the use of the elastomeric pump with 5-FU, supported by visual materials and an educational booklet developed by the researchers based on current literature and expert opinion
Eligibility Criteria
You may qualify if:
- Diagnosed with cancer,
- Able to understand Turkish and literate,
- Medically fit to participate in the study,
- Willing to participate in the study,
- Aged 18 years or older.
You may not qualify if:
- Diagnosed with a psychiatric disorder,
- Unable to communicate effectively,
- Refusing to participate in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Biruni University
Istanbul, Zeytinburnu, 34015, Turkey (Türkiye)
Koç University Hospital
Istanbul, Turkey (Türkiye)
Related Publications (29)
Yilmaz SG, Arslan S. Effects of progressive relaxation exercises on anxiety and comfort of Turkish breast cancer patients receiving chemotherapy. Asian Pac J Cancer Prev. 2015;16(1):217-20. doi: 10.7314/apjcp.2015.16.1.217.
PMID: 25640354RESULTUslu, Y., Olgun, N., Karanlık, H., User, İ. (2019). Port kateter uygulamaları: kanserli hastaların deneyimlerine ilişkin niteliksel bir çalışma. Acıbadem Üniversitesi Sağlık Bilimleri Dergisi, 10(3), 464-472.
RESULTUlusoy, M., Şahin, N., Erkmen, H. (1998). Turkish version of The Beck Anxiety Inventory: Psychometric properties. Journal of Cognitive Psychother, 12, 28-35.
RESULTTemiz G, Durna Z. Evaluation of Quality of Life and Health Care Needs in Cancer Patients Receiving Chemotherapy. J Cancer Educ. 2020 Aug;35(4):796-807. doi: 10.1007/s13187-019-01533-2.
PMID: 31054110RESULTShoemaker LK, Arora U, Rocha Lima CM. 5-fluorouracil-induced coronary vasospasm. Cancer Control. 2004 Jan-Feb;11(1):46-9. doi: 10.1177/107327480401100207.
PMID: 14749623RESULTStewart T, Pavlakis N, Ward M. Cardiotoxicity with 5-fluorouracil and capecitabine: more than just vasospastic angina. Intern Med J. 2010 Apr;40(4):303-7. doi: 10.1111/j.1445-5994.2009.02144.x.
PMID: 20529041RESULTSayin Y, Aksoy G. The effect of analgesic education on pain in patients undergoing breast surgery: within 24 hours after the operation. J Clin Nurs. 2012 May;21(9-10):1244-53. doi: 10.1111/j.1365-2702.2011.04009.x. Epub 2012 Mar 8.
PMID: 22404338RESULTPu YL, Li ZS, Zhi XX, Shi YA, Meng AF, Cheng F, Ali A, Li C, Fang H, Wang C. Complications and Costs of Peripherally Inserted Central Venous Catheters Compared With Implantable Port Catheters for Cancer Patients: A Meta-analysis. Cancer Nurs. 2020 Nov/Dec;43(6):455-467. doi: 10.1097/NCC.0000000000000742.
PMID: 31464692RESULTPinelli F, Cecero E, Degl'Innocenti D, Selmi V, Giua R, Villa G, Chelazzi C, Romagnoli S, Pittiruti M. Infection of totally implantable venous access devices: A review of the literature. J Vasc Access. 2018 May;19(3):230-242. doi: 10.1177/1129729818758999. Epub 2018 Mar 7.
PMID: 29512430RESULTPaleczny J, Banys-Jafernik B, Gazurek K, Kierpiec K, Szczerba H, Zipser P. Long-term totally implantable venous access port systems--one center experience. Anaesthesiol Intensive Ther. 2013 Oct-Dec;45(4):215-22. doi: 10.5603/AIT.2013.0042.
PMID: 24407899RESULTPaiva BS, de Carvalho AL, Kolcaba K, Paiva CE. Validation of the Holistic Comfort Questionnaire-caregiver in Portuguese-Brazil in a cohort of informal caregivers of palliative care cancer patients. Support Care Cancer. 2015 Feb;23(2):343-51. doi: 10.1007/s00520-014-2370-5. Epub 2014 Aug 2.
PMID: 25082367RESULTÖztaş, M., Alkan, İ., Öztaş, B. (2022). Determination of nursing practices regarding port catheter care. J Med Palliat Care, 3(1), 33-38.
RESULTOzden D, Caliskan N. Turkish nurses' level of knowledge regarding implantable port catheter care. Jpn J Nurs Sci. 2012 Jun;9(1):1-8. doi: 10.1111/j.1742-7924.2011.00177.x. Epub 2011 Mar 14.
PMID: 22583935RESULTÖnder, H., Tekbaş, G., Turmak, M., İnal, A., Ekici, F., Gümüş, H, Önder, A. (2014). Image-guided subcutaneous port implantation in patients with malignant diseases. European Journal of General Medicine, 1, 1-6.
RESULTOdabas H, Ozdemir NY, Ziraman I, Aksoy S, Abali H, Oksuzoglu B, Isik M, Civelek B, Dede D, Zengin N. Effect of port-care frequency on venous port catheter-related complications in cancer patients. Int J Clin Oncol. 2014 Aug;19(4):761-6. doi: 10.1007/s10147-013-0609-7. Epub 2013 Aug 27.
PMID: 23978939RESULTMcCarthy M, Glick R, Green J, Plummer K, Peters K, Johnsey L, Deluca C. Comfort First: an evaluation of a procedural pain management programme for children with cancer. Psychooncology. 2013 Apr;22(4):775-82. doi: 10.1002/pon.3061. Epub 2012 Mar 13.
PMID: 22416039RESULTKolcaba K, Schirm V, Steiner R. Effects of hand massage on comfort of nursing home residents. Geriatr Nurs. 2006 Mar-Apr;27(2):85-91. doi: 10.1016/j.gerinurse.2006.02.006.
PMID: 16638478RESULTKim KS, Kwon SH. Comfort and quality of life of cancer patients. Asian Nurs Res (Korean Soc Nurs Sci). 2007 Sep;1(2):125-35. doi: 10.1016/S1976-1317(08)60015-8. Epub 2008 Dec 9.
PMID: 25030749RESULTKia A, Waterson J, Bargary N, Rolt S, Burke K, Robertson J, Garcia S, Benavoli A, Bergstrom D. Determinants of Intravenous Infusion Longevity and Infusion Failure via a Nonlinear Model Analysis of Smart Pump Event Logs: Retrospective Study. JMIR AI. 2023 Sep 13;2:e48628. doi: 10.2196/48628.
PMID: 38875535RESULTKesici, S., Tuna, V., Özkan, S., Cengiz, E., Türkmen, A. (2017). Venöz port kateter implantasyonu uygulanan hastaların retrospektif analizi. Cukurova Medical Journal, 42, 604-605.
RESULTKaykunoğlu, M., Tambağ, H. (2022). Ayaktan Kemoterapi Alan Hastaların Sosyal Destek ve Anksiyete Düzeylerinin Belirlenmesi. Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi, 9(3), 429-435.
RESULTHou YF, Zhao AP, Feng YX, Cui XN, Wang LL, Wang LX. Nurses' knowledge and attitudes on comfort nursing care for hospitalized patients. Int J Nurs Pract. 2014 Dec;20(6):573-8. doi: 10.1111/ijn.12200. Epub 2013 Oct 11.
PMID: 24118635RESULTEsfahani H, Ghorbanpor M, Tanasan A. Implantable Port Devices, Complications and outcome in Pediatric Cancer, a Retrospective Study. Iran J Ped Hematol Oncol. 2016;6(1):1-8. Epub 2016 Mar 15.
PMID: 27222696RESULTÇıtlık, S.C., Çevik, S., Özden, G. (2018). Genel Konfor Ölçeği Kısa Formunun Türkçe geçerlik ve güvenirlik çalışması. Diyabet, Obezite ve Hipertansiyonda Hemşirelik Forumu, 10(2), 16-22.
RESULTChefchaouni AC, Ouedraogo JM, Bechar H, Belahcen MJ, Rahali Y. Retrospective analysis of failures of ambulatory elastomeric pumps containing 5-FU in a hospital pharmacy unit. J Oncol Pharm Pract. 2023 Jan;29(1):125-129. doi: 10.1177/10781552211060290. Epub 2021 Nov 16.
PMID: 34783287RESULTCan, A., Hintistan, S. (2021). Kemoterapi alan kanser hastalarının konfor düzeylerinin değerlendirilmesi. Bezmialem Science, 9(3), 310-316.
RESULTBurucu R, Turkben Polat H. Spiritual Well-Being Levels and Self-Care Agency of Patients Receiving Chemotherapy With Port Catheter: A Correlational, Descriptive Study. Holist Nurs Pract. 2024 Nov-Dec 01;38(6):331-340. doi: 10.1097/HNP.0000000000000655. Epub 2024 Oct 14.
PMID: 39422619RESULTBeck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988 Dec;56(6):893-7. doi: 10.1037//0022-006x.56.6.893. No abstract available.
PMID: 3204199RESULTAbe T, Matsuzaka K, Nakayama T, Otsuka M, Sagara A, Sato F, Yumoto T. Impact of air temperature and drug concentration on liquid emission from elastomeric pumps. J Pharm Health Care Sci. 2021 Jan 5;7(1):1. doi: 10.1186/s40780-020-00185-5.
PMID: 33397508RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- No masking was performed due to the nature of the educational intervention.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assist. Prof.
Study Record Dates
First Submitted
July 2, 2025
First Posted
July 11, 2025
Study Start
July 8, 2025
Primary Completion
August 11, 2025
Study Completion
September 8, 2025
Last Updated
June 15, 2026
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share
Data will only be shared upon reasonable request and subject to approval by the ethics committee.